What is happening in UK diabetes research
The UK has long shaped how diabetes is treated worldwide. The NHS Path to Remission programme, which offers a total diet replacement approach for people recently diagnosed with type 2 diabetes, grew directly out of research done by teams in Glasgow and Newcastle. That landmark trial showed that around half of participants reached remission at one year on a structured, calorie-controlled diet, and follow-up work continues to track whether the benefits hold over time.
Researchers are now asking why so many eligible people never take up remission programmes in the first place. The NewDAWN trial at the University of Oxford is testing whether offering a wider choice of weight loss programmes increases participation and leads to more people achieving remission. Around 1,800 people diagnosed with type 2 diabetes within the last six years are being recruited through GP practices across the country, which means your local surgery could be involved.
Technology is a second focus of current research. The FreeDM2 trial, led by the University of Nottingham and Imperial College London, compared real-time continuous glucose monitoring with traditional finger-prick testing in adults with type 2 diabetes using basal insulin. Results published in The Lancet Diabetes and Endocrinology found that continuous monitoring produced clearly better blood glucose control. That kind of evidence shapes what the NHS offers patients later.
Type 1 diabetes saw a milestone in 2026 when teplizumab, the first immunotherapy shown to slow progression of the condition, was approved for NHS use in England and Wales. Trials continue around it, alongside studies such as Address 2, which examines people recently diagnosed with type 1 diabetes and their siblings, with recruitment running until early this year.
Why many people hesitate
Even with all this activity, most people with diabetes have never been asked to join a study. Three concerns surface again and again. Finding out which trials exist and whether you qualify can feel like detective work, because eligibility criteria are often strict, covering age, time since diagnosis, current medication, and HbA1c levels. Then there is the worry that joining a trial means stepping outside normal NHS care. In practice, you stay under your usual diabetes team, and participation is voluntary at every stage. Practical questions weigh heavily too, from time off work to travel to research sites and what actually happens on the day.
The safeguards are worth knowing. Every study in the UK must be reviewed by a research ethics committee before it can start, and consent is informed consent. The team explains the purpose, the schedule of visits, potential side effects, and your right to withdraw at any time without affecting your standard care.
Comparing the main types of studies
| Type of study | Example in the UK | What it involves | Cost or compensation | Main benefits | Things to weigh up |
|---|
| Weight and remission | NewDAWN at the University of Oxford | Regular appointments over several months | Travel expenses usually covered; no charge to you | Real chance of remission with NHS-linked follow-up | Demands a long-term commitment to diet change |
| Glucose monitoring | FreeDM2 (CGM versus finger-prick) | Sensor wear plus clinic visits | Monitoring devices provided as part of the study | Better time in range; fewer finger pricks | Wearing a sensor can take getting used to |
| New medication | LY3457263, Phase 2 with sites in Birmingham, Blackpool, Bristol and Newcastle | Scheduled visits and blood tests | Some industry studies pay for time and travel | Access to a novel treatment with close monitoring | Placebo is possible; long-term effects unknown |
| Type 1 early-stage | Address 2 and related studies | Blood samples plus questionnaires | Travel covered in most cases | Helps understanding of type 1 and its early signs | Recruitment windows can close quickly |
On compensation, one industry study advertised in the UK, involving a 17-night inpatient stay, offered £3,875 to participants plus travel expenses. That is at the higher end. Most studies reimburse travel, and many offer smaller payments for time, so always ask what a specific trial covers rather than assuming.
How to find and join a trial
Start with your GP or diabetes specialist nurse. NHS research teams are usually glad to point you toward local studies, and your consultant can tell you whether any current trial fits your situation. It also helps to register your details with national programmes.
Diabetes UK works with the British Research Panel to match people with suitable research, and the charity's website lists open studies across the country. For type 1 diabetes, Breakthrough T1D runs a clinical trial finder and maintains a dedicated list of recruiting studies, from the SOPHIST trial to T1D-Plus. If you live in Scotland, the NHS Research Scotland Diabetes Register will match you with studies that may suit you. Alongside these, the ClinicalTrials.gov and ISRCTN registries let you search by condition, phase, and city, though a clinician should help you interpret the entries.
Before you join, you will go through a screening visit. The research team checks your eligibility, runs baseline tests, and walks you through the consent form. Take time to ask about appointment timing, whether visits can fit around work hours, and how far you will need to travel. One participant in a CGM study described the experience this way: seeing her glucose readings in real time showed her exactly how evening meals affected her levels, something finger-prick testing had never revealed. Even when a new treatment does not work for an individual, participants consistently report learning more about their own condition, and the habits often carry over into daily life.
A gentle nudge
Diabetes research in the UK is moving faster than ever, from remission diets to continuous monitors and the first immunotherapy for type 1 diabetes. None of it advances without volunteers. If you have ever wondered whether your diabetes could be managed better, or whether a treatment might suit you more closely, a trial could be worth exploring.
The next step is small. Mention your interest at your next diabetes appointment, or register with Diabetes UK's research matching service today. Asking a question commits you to nothing. It simply opens the door to options your care team may not have mentioned.
研究の知恵